Ubs Asset Management Americas Inc Edwards Lifesciences Corp Transaction History

Ubs Asset Management Americas Inc

$381 Billion
Q3 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 6,005,789 shares of EW stock, worth $407 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

6,005,789

Previous 5,944,514 1.03%

Holding current value

$407 Million

Previous $549 Million 27.82%

% of portfolio

0.1%

Previous 0.16%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$59.7 - $93.78 $3.66 Million - $5.75 Million	61,275 Added 1.03%	6,005,789 $396 Million
Q2 2024 Aug 13, 2024	BUY	$84.3 - $94.31 $130 Million - $146 Million	1,545,063 Added 35.12%	5,944,514 $549 Million
Q1 2024 May 15, 2024	BUY	$72.54 - $95.56 $29.5 Million - $38.9 Million	406,989 Added 10.19%	4,399,451 $420 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $8.05 Million - $10.1 Million	130,458 Added 3.38%	3,992,462 $304 Million
Q3 2023 Nov 13, 2023	SELL	$69.28 - $93.38 $5.74 Million - $7.73 Million	-82,832 Reduced 2.1%	3,862,004 $268 Million
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $13.8 Million - $15.7 Million	185,662 Added 4.94%	3,944,836 $326 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $4.93 Million - $6.31 Million	72,201 Added 1.96%	3,759,174 $280 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $74.5 Million - $97 Million	-904,201 Reduced 19.69%	3,686,973 $305 Million
Q2 2022 Aug 12, 2022	SELL	$86.5 - $128.27 $22.8 Million - $33.8 Million	-263,361 Reduced 5.43%	4,591,174 $437 Million
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $178 Million - $224 Million	-1,745,067 Reduced 26.44%	4,854,535 $571 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $234 Million - $287 Million	2,198,164 Added 49.94%	6,599,602 $855 Million
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $9.64 Million - $11.5 Million	93,674 Added 2.17%	4,401,438 $498 Million
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $56.4 Million - $70.5 Million	672,520 Added 18.5%	4,307,764 $446 Million
Q1 2021 May 14, 2021	SELL	$78.68 - $90.67 $72 Million - $82.9 Million	-914,799 Reduced 20.11%	3,635,244 $304 Million
Q4 2020 Mar 01, 2021	SELL	$71.69 - $91.23 $86.6 Million - $110 Million	-1,207,794 Reduced 20.98%	4,550,043 $415 Million
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $35.2 Million - $45.8 Million	524,179 Added 10.02%	5,757,837 $460 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $202 Million - $270 Million	3,510,123 Added 203.66%	5,233,658 $362 Million
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $6.74 Million - $10.4 Million	128,616 Added 8.06%	1,723,535 $108 Million
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $30.1 Million - $34.5 Million	419,980 Added 35.74%	1,594,919 $124 Million
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $14.9 Million - $18.2 Million	241,326 Added 25.85%	1,174,939 $86.1 Million
Q2 2019 Aug 15, 2019	BUY	$55.74 - $64.41 $4.12 Million - $4.76 Million	73,853 Added 8.59%	933,613 $0
Q1 2019 May 14, 2019	BUY	$47.89 - $64.05 $3.48 Million - $4.66 Million	72,708 Added 9.24%	859,760 $0
Q4 2018 Feb 13, 2019	BUY	$46.41 - $56.94 $2.01 Million - $2.47 Million	43,296 Added 5.82%	787,052 $40.2 Million
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $53,057 - $67,372	-1,161 Reduced 0.16%	743,756 $0
Q2 2018 Aug 14, 2018	BUY	$42.45 - $51.3 $307,592 - $371,719	7,246 Added 0.98%	744,917 $0
Q1 2018 May 14, 2018	BUY	$37.19 - $47.45 $3.41 Million - $4.36 Million	91,809 Added 14.21%	737,671 $0
Q4 2017 Feb 09, 2018	BUY	$33.79 - $39.39 $911,282 - $1.06 Million	26,969 Added 4.36%	645,862 $0
Q3 2017 Nov 13, 2017	BUY	$36.29 - $38.83 $22.5 Million - $24 Million	618,893	618,893 $0

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Edwards Lifesciences Corp Transaction History